Richard Baron

Current City, State, Country

Biography

Richard A. Baron has been on the Board of Yetzirah since March of 2025. Professionally, Richard has served as Senior Vice President and Chief Financial Officer for the following companies: Zynerba Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery; Globus Medical Inc., a publicly traded musculoskeletal implant manufacturer; Avid Radiopharmaceuticals, Inc., a biotech company that developed an imaging agent for Alzheimers, which was sold to Eli Lilly and Company; eResearch Technology, Inc.; Animas Corporation through its sale to Johnson; Johnson; Genex Services, LLC, a managed care provider for workers compensation and disability; and Marsam Pharmaceuticals Inc., a generic manufacturer of injectable anti-infectives. Richard has also been an independent consultant and a financial consultant for troubled companies with a major accounting firm. He has been a Board Member for various early-stage biotech and technology companies.

Richard has held Board and Treasurer positions at Synagogues in Philadelphia suburbs, Southwest Florida, and a Jewish Camping organization. He actively volunteers with various nature conservation nonprofits and has served as a mentor to students in numerous university and high school academic and entrepreneurial programs.

Richard holds an B.S. in Economics with a concentration in Accounting from the Wharton School of the University of Pennsylvania. He is also a former Certified Public Accountant in Pennsylvania.

Education

Wharton School of the University of Pennsylvania, B.S.